NLRP3 and metabolic dysfunction-associated steatotic liver disease: The present study demonstrated that verapamil inhibited TXNIP expression in the liver of mice with NAFLD, suggesting that the protective effects of verapamil may be due to inhibition of TXNIP/NLRP3 pathways.